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Abstract
Background: The burden of hypertension is high in Africa, and due to rapid population growth and ageing, the exact
burden on the continent is still far from being known. We aimed to estimate the prevalence and awareness rates of
hypertension in Africa based on the cut off ‘‘$140/90 mm Hg’’.
Methods:We conducted a systematic search of Medline, EMBASE and Global Health. Search date was set from January 1980
to December 2013. We included population-based studies on hypertension, conducted among people aged $15 years and
providing numerical estimates on the prevalence of hypertension in Africa. Overall pooled prevalence of hypertension in
mixed, rural and urban settings in Africa were estimated from reported crude prevalence rates. A meta-regression
epidemiological modelling, using United Nations population demographics for the years 1990, 2000, 2010 and 2030, was
applied to determine the prevalence rates and number of cases of hypertension in Africa separately for these four years.
Results: Our search returned 7680 publications, 92 of which met the selection criteria. The overall pooled prevalence of
hypertension in Africa was 19.7% in 1990, 27.4% in 2000 and 30.8% in 2010, each with a pooled awareness rate (expressed
as percentage of hypertensive cases) of 16.9%, 29.2% and 33.7%, respectively. From the modelling, over 54.6 million cases of
hypertension were estimated in 1990, 92.3 million cases in 2000, 130.2 million cases in 2010, and a projected increase to
216.8 million cases of hypertension by 2030; each with an age-adjusted prevalence of 19.1% (13.9, 25.5), 24.3% (23.3, 31.6),
25.9% (23.5, 34.0), and 25.3% (24.3, 39.7), respectively.
Conclusion: Our findings suggest the prevalence of hypertension is increasing in Africa, and many hypertensive individuals
are not aware of their condition. We hope this research will prompt appropriate policy response towards improving the
awareness, control and overall management of hypertension in Africa.
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Introduction
Hypertension and other cardiovascular diseases rank among the
leading causes of disabilities and deaths from non-communicable
diseases (NCDs) in Africa [1,2], with rising prevalence and death
rates now observed more in young and active adults [3]. Recently,
the African Union (AU) reported that hypertension is one of the
greatest health challenges after HIV/AIDS in the continent [4].
This is in fact a priority globally as conclusions from the 2011
United Nations high level meeting on NCDs focus on a reduction
of hypertension and other NCDs, especially in Africa, where the
burden is rising at a faster rate compared to other parts of the
world [5]. Worldwide, cardiovascular diseases account for about
17 million deaths, with complications from poorly controlled
hypertension resulting in over 7.5 million deaths and 57 million
disability adjusted life years (DALYS) [6].
The relatively higher prevalence of hypertension in Africa has
been linked to population growth and ageing, rising urbanization,
mass migration from rural to urban areas, and an increased uptake
of western lifestyles including tobacco and alcohol consumption
[3,7]. Public health response from the governments of many
African nations still remains low, as research findings show that a
high number of hypertensive individuals are currently unaware of
their condition [8]. Many African countries are yet to implement
high blood pressure awareness and control programmes on a
population-wide scale, even to people with very high risk of
cardiovascular complications [9]. Even with a widely popularised
availability of hypertension treatments in some African countries
[10], reports show that many rural dwellers are still faced with lack
of antihypertensive medications and poor management of cases of
hypertension [11]. The WHO has recommended a need for strong
public health policies, multisectoral approach, and available and
affordable treatment options toward reducing this growing burden
of hypertension in Africa [2].
Despite reports of a higher prevalence of hypertension in Africa
compared to other world regions [2], public health experts believe
the real burden is still far from being known [12]. Many studies in
the 1980s and early 1990s were based on the old definition of
hypertension ($160/95 mm Hg) [8,12]. These surveys may
possibly underestimate the prevalence of hypertension in Africa
in comparison to newer surveys based on $140/90 mm Hg.
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Moreover, even within studies based on similar case definitions,
the variations in reported estimates still suggest the need for more
systematic and accurate estimates from larger number of studies
towards appropriately informing health service planning and a
better response to hypertension in Africa. For example, the World
Health Organization (WHO) reported that the prevalence of
hypertension in the African region was highest globally in 2008,
with an estimated prevalence of 46% [13]. This, though vital for
instituting relevant public health response in the continent,
elucidates a conflicting state of data in comparison to other
hypertension prevalence estimates in Africa which are relatively
lower [14,15]. Thus, with an increased research output on
hypertension in Africa in the last two decades, a systematic review
of population-based studies was conducted towards providing an
improved continent-wide estimate of the prevalence and aware-
ness rate of hypertension in Africa, which hopefully may
encourage healthy public health policy for a value-added
management of hypertension in the region.
Methods
Search strategy
After identifying Medical Subject Headings (MESH) and
keywords, a final search strategy was developed. Searches were
conducted on three main databases: Medline, EMBASE and
Global Health. The search date was set from January 1980 to
December 2013. African countries were as listed on the World
Bank list of economies (July 2012) [16]. See Table 1 for details of
the search terms.
Selection criteria and case definitions
Cross-sectional population- and/or community-based studies on
hypertension were included, published on or after 1980, conduct-
ed among people aged $15 years, and providing numerical
estimates on the prevalence of hypertension in Africa. Studies
conducted before 1980, hospital-based, without numerical esti-
mates, on non-human subjects, and that were mainly reviews were
all excluded. There were no language restrictions.
Case definitions of hypertension across retained studies comply
with the following:
i. systolic blood pressure ($140 mm Hg) and/or diastolic blood
pressure ($90 mm Hg) and/or self-reported use of antihy-
pertensive medications;
ii. the sixth and seventh report of the Joint National Committee
on prevention, detection, evaluation, and treatment of high
blood pressure (JNC 6 & 7) [17,18]; and
iii. the 1999 and 2003 World Health Organization/Internation-
al Society of Hypertension (WHO/ISH) definitions and
classification of blood pressure levels [19]
See Table 2 for details. For the definition of the awareness rate
of hypertension in this study, we included studies estimating the
prevalence of hypertension based on the definitions above, with
awareness rate also being estimated among all identified cases of
hypertension and defined as self-report by respondents of any prior
diagnosis of hypertension by a doctor or certified health care
professional, and excluding women diagnosed during pregnancy,
as described by the WHO [19].
Quality criteria
Studies retained were assessed for the following quality:
i. Study design: Under this, flaws in the design and execution of
study were examined. Basically, this assesses methods of
estimation of sample size and sampling methods across
studies, and the methods of dealing with design specific issues
such as: training of study investigators, adherence to
Table 1. Search terms.
# Search terms
1 africa/ or africa, northern/ or algeria/ or egypt/ or libya/ or morocco/ or africa, central/ or cameroon/ or central african republic/ or chad/ or congo/ or
‘‘democratic republic of the congo’’/ or equatorial guinea/ or gabon/ or africa, eastern/ or burundi/ or djibouti/ or eritrea/ or ethiopia/ or kenya/ or rwanda/ or
somalia/ or sudan/ or tanzania/ or uganda/ or africa, southern/ or angola/ or botswana/ or lesotho/ or malawi/ or mozambique/ or namibia/ or south africa/ or
swaziland/ or zambia/ or zimbabwe/ or africa, western/ or benin/ or burkina faso/ or cape verde/ or cote d’ivoire/ or gambia/ or ghana/ or guinea/ or guinea-
bissau/ or liberia/ or mali/ or mauritania/ or niger/ or nigeria/ or senegal/ or sierra leone/ or togo/
2 exp vital statistics/ or exp incidence/
3 (incidence* or prevalence* or morbidity or mortality).tw.
4 (disease adj3 burden).tw.
5 exp ‘‘cost of illness’’/
6 exp quality-adjusted life years/
7 QALY.tw.
8 Disability adjusted life years.mp.
9 (initial adj2 burden).tw.
10 exp risk factors/
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12 cardiovascular diseases/ or heart diseases/ or exp hypertension/ or peripheral vascular diseases/
13 Hypertensive heart disease.mp. [mp= title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer,
device trade name, keyword]
14 12 or 13
15 1 and 11 and 14
16 limit 15 to (humans and yr = ‘‘1980 -Current’’)
doi:10.1371/journal.pone.0104300.t001
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standardized protocol for blood pressure measurement, pre-
testing and reviewing questionnaires before data entry, and
addressing recall and interviewer’s bias appropriately;
ii. Study analysis: This assessed the appropriateness of statistical
and analytical methods employed across studies in the
estimation of hypertension prevalence;
iii. Generalizability to the African population: This broadly
assessed if the sample size was representative of a larger
population that can be generalized to the total African
population
An adaptation of the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) guidelines was applied in
the final quality grading of studies [20]. See Box S1, Table S1
and Table S2 in File S1 for details.
Data extraction and analysis
All extracted data were stored in Microsoft Excel file format. A
parallel search and double extraction were conducted by the
authors. Data were abstracted systematically on sample size, mean
age or age range, number of hypertension cases, and the respective
age- and sex-specific prevalence rates. These were sorted into
mixed, urban and rural settings (based on studies that reported
them). For studies conducted on the same study site, population or
cohort, the first chronologically published study was retained, and
all additional data from other studies were included in the selected
paper.
From all studies, reported crude prevalence rates of hyperten-
sion (all expressed as percentages) were pooled, and reported
separately for north Africa and sub-Saharan Africa (central, east,
south and west), and with rates for urban and rural settings
estimated. These were further categorized into 1990, 2000 and
2010, as obtained from studies conducted before 1995, from 1995
to 2004, from 2005 to 2013, respectively. As noted above,
awareness rate of hypertension was estimated as number of people
who reported being hypertensive, expressed as a percentage of
total number of people in the study population having hyperten-
sion. Pooled awareness rates of hypertension for 1990, 2000, and
2010, and rates across mixed, urban and rural settings were
estimated, respectively.
Description of the modelling
For the modelling and estimation of the total cases of
hypertension in Africa, a meta-regression epidemiological model
was developed, and applied on crude prevalence rates, sample
sizes and respective mean age from all data points. In this model,
all data points (mainly the crude prevalence rates and mean age)
were plotted on a graph on Microsoft Excel, with all extracted
crude prevalence rates plotted on the y-axis, i.e. dependent
variable, and mean ages corresponding to each prevalence rate are
plotted on the x-axis, i.e. independent variable. To account for
variation in sample sizes from each data point, bubbles were
generated on the graph, with the size of each bubble correspond-
ing to the respective sample size reported. Although, it is well
known that the prevalence of hypertension in the population
significantly increases with age [21], the relationship between age
and the disease may not be necessarily linear. Therefore, we
experimented with the models based on linear, logarithmic,
exponential, Poisson, polynomial, power function and moving
average statistical analyses, respectively, and chose the one which
was the most predictive, i.e. in which the proportion of variance
(R2) of the disease prevalence explained by age was the greatest.
On the model therefore, the fitted curve explaining the largest
proportion of variance (best fit) was applied. The equation
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generated from the fitted curve was then used to determine the
prevalence of hypertension in Africa at midpoints of the United
Nations (UN) population 5-year age-group population estimates
for Africa, for the years 1990, 2000, 2010, respectively [22], while
an overall model was developed from all data points (1980–2013)
and used to predict the number of hypertension cases and
prevalence rates for 2030. All statistical analyses were conducted
on Microsoft Excel and Stata 13.1 (Copyright 1985–2013 Stata
Corp LP).
Results
Systematic review
The search returned 7680 publications: Medline (2205),
EMBASE (4073) and Global Health (1402). An additional 3
studies were included from other sources (Google Scholar and
reference list of relevant reviews). After excluding duplicates, 5227
studies remained. On screening titles for relevance (hypertension
studies conducted primarily in an African population setting), 4936
articles were excluded, giving a total of 291 full texts that were
assessed. 82 articles did not report hypertension prevalence or
population denominators from which prevalence rates can be
calculated, 75 articles did not specify study designs and/or clarify
case definitions of hypertension, and 42 articles were based on
blood pressures base-line of 160/90 mm Hg. A total of 92 studies
were finally retained for qualitative synthesis and quantitative
analysis (Figure 1).
Study characteristics
There were 92 studies conducted across 101 study sites in 31
African countries. Central Africa had 10 study sites, Eastern Africa
21, Northern Africa 12, Southern Africa 15, and Western Africa
43. Nigeria had the highest number of publications with 26 study
sites; Ghana and South Africa follow with 7 study sites each, while
Cameroon, Tanzania and Tunisia had 6 study sites each (see
Tables 3 and 4).
73% of studies were completed within a one year, with over
50% carried out in urban settings. The overall sample size from all
retained studies was 197734, with a mean and median of 1958 and
1200 respectively. From all studies, the weighted mean systolic and
Figure 1. Flow diagram of search results.
doi:10.1371/journal.pone.0104300.g001
Table 3. Study distribution.
Country Study sites
Central
Cameroon 6
Chad 1
DR Congo 2
Rwanda 1
East
Eritrea 1
Ethiopia 5
Kenya 3
Seychelles 1
Sudan 1
Tanzania 6
Uganda 4
North
Algeria 3
Egypt 2
Morocco 1
Tunisia 6
South
Angola 2
Madagascar 1
Malawi 2
Mozambique 1
Namibia 1
South Africa 7
Zambia 1
West
Benin 1
Burkina Faso 1
Gambia 1
Ghana 7
Guinea 2
Liberia 1
Nigeria 26
Senegal 2
Togo 2
Duration of study
,1 year 74
1–3 years 22
.3 years 5
Sample size
,1000 54
1001–3000 37
.3000 10
Study setting
Rural 47
Urban 50
Mixed (sites overlap with urban and rural) 33
doi:10.1371/journal.pone.0104300.t003
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Table 4. Summary of data from all studies.
Country, Setting Study period Diagnostic criteria
Mean age
(years)
Prevalence %
(all)
Prevalence %
(men)
Prevalence %
(women)
CENTRAL
Cameroon, Mixed [44] 1995 $140/90 mmHg 49.5 16.9 17.7 16.3
Cameroon, Mixed [45] 1991 $140/90 mmHg 41.75 7.07 8.92 5.69
Cameroon, Mixed [46] 1994 $140/90 mmHg 54.5 18.8 20.2 17.8
Cameroon, Mixed [46] 2003 WHO/ISH 1999 54.5 38.34 40.9 36.5
Cameroon, Urban) [47] 2003 WHO/ISH 1999 31.35 24.6 25.6 23.1
Cameroon, Urban [47] 2004 WHO/ISH 1999 31.35 20.8 - -
Chad, Rural [48] 2004 WHO/ISH 2003 35 16.4 12.2 21.8
DR Congo, Mixed [49] 2009–10 WHO/ISH 2003 54.5 40.2 - -
DR Congo, Urban [50] 1983–84 $140/90 mmHg 42.5 16.7 22.1 12.4
Rwanda, Rural [51] 2007 JNC 7 42.2 16.0 16.0 16.0
EAST
Eritea, Mixed [52] 2004 $140/90 mmHg 39.5 16.0 16.88 15.28
Ethiopia, Mixed [28] 2008 JNC 7, WHO/ISH 2003 36.08 9.9 - -
Ethiopia, Urban [53] 2012 JNC 7 51.4 28.3 26 30.3
Ethiopia, Urban [54] 2009 $140/90 mmHg 50.5 19.1 22 14.9
Ethiopia, Urban [55] 2006 $140/90 mmHg 49.5 30.0 31.5 28.9
Ethiopia, Urban [56] 2009–2010 JNC 7 42.9 17.7 20.0 14.3
Kenya, Rural [57] 2009–11 WHO/ISH 2003 40.9 20.2 - -
Kenya, Mixed [58] 2007–08 $140/90 mmHg 69.5 50.1 - -
Kenya, Urban [59] 2009–09 $140/90 mmHg 48.5 12.3 12.7 12
Seychelles, Mixed [60] 2004 $140/90 mmHg 44.5 31.6 38.4 24.8
Sudan, Urban [27] 1988–89 $140/90 mmHg 35 7.5 - -
Tanzania, Urban [61] 1998–99 WHO/ISH 1999 54.5 28.9 27.1 30.2
Tanzania, Rural [51] 2007 JNC 7 42.8 27 28 24
Tanzania, Rural [24] 2009–2010 WHO/ISH 2003 76 69.9 62.2 75.8
Tanzania, Rural [62] 1996 WHO/ISH 1999 39.95 29.2 30 28.6
Tanzania, Rural 1996 $140/90 mmHg 54.5 31.9 32.2 31.5
Tanzania, Urban [57] 2009–11 WHO/ISH 2003 36.8 19 - -
Uganda, Rural [63] 2008–09 $140/90 mmHg 32.75 22.3 22.5 22.6
Uganda, Rural [64] 2011 $140/90 mmHg 42.5 20.5 20.7 20.4
Uganda, Mixed [65] 2012 $140/90 mmHg 35.15 21.8 22.3 21.7
Uganda, Rural [66] 2006 $140/90 mmHg 42 30.4 25.4 34
NORTH
Algeria, Rural) [67] 2010 WHO/ISH 2003 58.5 50.2 51.3 49.7
Algeria, Urban [68] 2004–05 $140/90 mmHg 54.5 32.7 24.5 40.6
Algeria, Peri-urban [69] 2006–07 $140/90 mmHg 55 44 41.2 46.7
Egypt, Mixed [70] 1991–93 $140/90 mmHg 45.6 26.3 25.7 26.9
Egypt, Rural [71] 1999–00 $140/90 mmHg 42.5 27.9 - -
Morocco, Mixed [72] 2000 $140/90 mmHg 51 39.6 37.2 41.3
Tunisia, Mixed [73] 2004–05 JNC 7 44.6 31.07 25.0 36.1
Tunisia, Mixed [74] 2004–05 $140/90 mmHg 49.6 30.6 27.3 33.1
Tunisia, Mixed [75] 2002–03 $140/90 mmHg 54.5 44.3 38.7 48.2
Tunisia, Urban [76] 1995 $140/90 mmHg 54.5 28.9 30 28.4
Tunisia, Rural [77] 2008–09 WHO/ISH 2003 72.3 52 45 55.5-
Tunisia, Mixed [25] 2002–03 $140/90 mmHg 69 69.3 - -
SOUTH
Angola, Urban [78] 2009–10 JNC 7 44.5 45.2 46.3 44.2
Angola, Mixed [79] 2011 $140/90 mmHg 41.5 23 26.4 19.8
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Table 4. Cont.
Country, Setting Study period Diagnostic criteria
Mean age
(years)
Prevalence %
(all)
Prevalence %
(men)
Prevalence %
(women)
Madagascar, Urban [80] 1996–97 $140/90 mmHg 32.75 23.3 24.9 21.7
Malawi, Rural [51] 2007 JNC 7 38.4 23 24.5 22
Malawi, Mixed [81] 2009 $140/90 mmHg 45.5 33.2 36.9 29.9
Mozambique, Mixed [82] 2005 WHO/ISH 1999 54.5 33.1 35.7 31.2
Namibia, Urban [57] 2009–11 WHO/ISH 2003 36.9 32 - -
South Africa, Rural [83] 2004–05 $140/90 mmHg 59.5 28.0 24.5 29.2
South Africa, Rural [84] 2010 $140/90 mmHg 54.5 26.2 20.8 28.5
South Africa, Mixed [23] 2008 $140/90 mmHg 65 77.3 74.4 79.6
South Africa, Mixed [85] 1982 $140/90 mmHg 41 41.6 45.6 37.75
South Africa, Mixed [86] 1990 $140/90 mmHg 40.5 21.5 19.2 23.4
South Africa, Peri-urban [87] 1996 $140/90 mmHg 42 27.1 31.9 23.4
South Africa, Rural [88] 2002 JNC 7 59.5 32.6 - -
Zambia, Urban [89] 2009–10 WHO/ISH 2003 57 34.8 38 33.3
WEST
Benin, Mixed [90] 2008 $140/90 mmHg 42.7 27.9 - -
Burkina Faso, Urban [91] 2004 $140/90 mmHg 54.5 40.2 - -
Gambia, Mixed [92] 1998–99 $140/90 mmHg 43.7 18.4 - -
Ghana, Rural [93] 2004–05 $140/90 mmHg 42.4 25.4 24.1 25.9
Ghana, Mixed [94] 2004 $140/90 mmHg 35.9 29.4 31.04 28.07
Ghana, Rural [95] 2003 $140/90 mmHg 53 32.8 - -
Ghana, Mixed [96] 2001 $140/90 mmHg 54.7 28.7 29.9 28
Ghana, Rural [97] 2006–07 $140/90 mmHg 53.5 35 37.2 34.1
Ghana, Rural [98] 2002–10 JNC 7. WHO/ISH 2003 66 24.1 25.7 22.5
Ghana, Rural [99] 2012 $140/90 mmHg 53.84 44.7 - -
Guinea, Mixed [100] 2003 $140/90 mmHg 62 31.4 - -
Guinea, Rural [101] 2001 $140/90 mmHg 45.5 45.2 - -
Liberia, Rural [102] 1991–92 $140/90 mmHg 54.5 12.5 - -
Nigeria, Mixed [103] 2010–11 JNC 6 71.1 34.7 - -
Nigeria, Semi-urban [104] 2007–08 JNC 7 44.2 36.57 36.79 36.39
Nigeria, Semi-urban [105] 2011–12 JNC 7, WHO/ISH 2003 41.5 25.2 24.7 24.7
Nigeria, Rural [106] 2010–11 $140/90 mmHg 57.3 44.5 49.3 42.3
Nigeria, Rural [107] 2012–13 JNC 7 41.3 20.2 20.5 20.1
Nigeria, Urban [108] 2006–10 JNC 7 41.9 33 38.3 27.8
Nigeria, Mixed [109] 2008 JNC 7 48.7 50.5 52 49.3
Nigeria, Rural [110] 2011 JNC 7 49.7 13.2 15 11.9
Nigeria, Urban [111] 1987–88 $140/90 mmHg 36.35 31.1 34 17
Nigeria, Mixed [44] 1995 $140/90 mmHg 49.5 14.5 14.7 14.3
Nigeria, Rural [112] 2005–06 WHO/ISH 2003 59.8 46.4 50.2 44.8
Nigeria, Semi-urban [113] 2012 $140/90 mmHg 31.7 47 30.1 16.8
Nigeria, Mixed [114] 2009 $140/90 mmHg 34.9 21.1 - -
Nigeria, Semi-urban [115] 2002–03 JNC 6, WHO/ISH 1999 55 21 23.3 16.4
Nigeria, Rural [57] 2009–11 WHO/ISH 2003 45.3 21 - -
Nigeria, Mixed [116] 2009–10 JNC 7 38.9 24.8 25.9 23.6
Nigeria, Semi-urban [117] 2011–12 $140/90 mmHg 50 32.5 - -
Nigeria, Urban [118] 2009–10 $140/90 mmHg 43.88 34.8 - -
Nigeria, Mixed [119] 2011–12 $140/90 mmHg 41.7 31.8 33.5 30.5
Nigeria, Urban [120] 2006–07 $140/90 mmHg 50.5 27.1 28.4 22.9
Nigeria, Rural [121] 2002–05 JNC 7 42.1 20.8 21.1 20.5
Nigeria, Urban) [122] 2007–08 $140/90 mmHg 41.6 33 28.1 36.4
Prevalence and Awareness Rates of Hypertension in Africa
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diastolic blood pressures were 129.6 mm Hg and 78.0 mm Hg
respectively. Studies were mostly conducted on people aged $20
years, with an estimated overall mean age of 47.4 years, ranging
from 30.7 to 76 years. For the age determination of subjects across
selected studies, birth certificates were mostly employed, and in the
absence of valid age-verification documents, subjects’ age were
determined from historical landmarks.
Prevalence and awareness rates of hypertension in Africa
Across all study settings, an elderly South African setting
recorded the highest prevalence of hypertension in 2008 (77.3%,
mean age 65 years) [23]. Other settings reporting higher
prevalence rates of hypertension were also in older adult
population surveys in Tanzania in 2010 (69.9%, mean age 76
years), Tunisia in 2003 (69.3%, mean age 69 years), and Senegal in
2009 (65.4%, mean age 69.5 years) respectively [24–26]. The
lowest prevalence rates of hypertension were recorded in Sudan
(7.5%, mean age 35 years) and Ethiopia (9.9%, mean age 36.1
years) in 1989 and 2008 respectively [27,28] (See Table 4 for
overall study characteristics).
The pooled crude prevalence in Northern Africa was higher
than in sub-Saharan Africa (SSA), with hypertension prevalence of
33.3% in Northern Africa and 27.8% in sub-Saharan Africa. In
other parts of SSA, Southern Africa recorded the highest
prevalence, with a prevalence of 34.6% (males 35.4%, females
34.2%). Western Africa had a prevalence of 27.3% (males 29.6,
females 28.2), Central Africa recorded 21.1% (males 21.5%,
females 19.3%), and Eastern Africa had 26.8% (males 25.0,
females 26.1) (see Table 5 for details). The overall pooled crude
prevalence (weighted means) of hypertension for Africa was 19.7%
(males 23.0%, females 20.2%) in 1990, 27.4% (males 26.9, females
28.4) in 2000, and 30.8% (males 29.7, females 31.4). There were
not huge differences in hypertension prevalence between urban
and rural dwellers, with the exception of 1990, where urban
dwellers recorded a prevalence of 17.2% (males 21.1, females
15.1), compared to 11.1% (males 9.4%, females 8.3%) recorded
among rural dwellers (with urban and rural dwellers having
prevalence of 26.1% versus 26.3% in 2000 and 29.6% versus
29.0% in 2010 respectively) (see Table 6 for details).
Across selected studies, there is evidence suggesting the
awareness of hypertension among people living with the disease
has been increasing since 1990; however, the overall awareness
rate still remains relatively low in many parts of Africa. From the
pooled analysis, a weighted awareness rate (expressed as a
percentage of cases of hypertension) of 16.9% was estimated in
1990, 29.2% in 2000 and 33.7% in 2010 (see Tables 5 and 6 for
details).
Modelled estimates of hypertension prevalence and
number of cases in Africa
The modelling indicated the overall cases and prevalence of
hypertension in Africa have been increasing since 1990. In adults
aged $20 years, 54.6 million cases of hypertension were estimated
in 1990 with an age-adjusted prevalence of 19.1% (13.9, 25.5),
92.3 million cases in 2000 with an age-adjusted prevalence of
24.3% (23.3, 31.6), 130.2 million cases in 2010 with an age-
adjusted prevalence of 25.9% (23.5, 34.0), and a projected increase
to 216.8 million cases of hypertension by 2030 with an age-
adjusted prevalence of 25.3% (24.3, 39.7). The general sex
distribution revealed the prevalence and number of cases of
hypertension were higher among men than women. Among men,
the prevalence and number of hypertension cases were both
projected to increase between 2010 and 2030. About 29.8 million
cases of hypertension were estimated in 1990 (21.2%, 95%CI:
16.5–29.6), 46.8 million cases in 2000 (25.1%, 95%CI: 22.9–31.0),
64.8 million cases in 2010 (26.1%, 95%CI: 23.6–33.6), and a
projected increase to 112.1 million cases of hypertension by 2030
(26.4%: 24.5–41.1). However, there was a drop in prevalence
among women between 2010 and 2030. 24.8 million cases of
hypertension were estimated in 1990 (17.1%, 95%CI: 13.4–27.0),
45.5 million cases in 2000 (23.6%, 95%CI: 21.5–33.3), 65.4
million cases in 2010 (25.7%, 95%CI: 21.7–35.4), and a projected
increase to 104.7 million cases of hypertension by 2030, with a
drop in prevalence to 24.3% (95%CI: 22.4–38.9) (see Tables 7–9
and Figures 2–5).
Discussion
This review provides an improved continent-wide estimate of
the prevalence and awareness rates of hypertension in Africa using
epidemiological modelling adjusted for age and sample size of the
population. Having included studies conducted across various
parts of Africa, the estimates may provide a close representation of
the prevalence and the number of cases of hypertension in the
continent.
From all studies, we estimated weighted mean systolic and
diastolic blood pressures of 129.6 mm Hg and 78.0 mm Hg,
respectively, with an overall mean age of 47.4 years. Our estimate
is comparable with the estimates reported by Danaei and
colleagues on the global trends of systolic blood pressure, with
Table 4. Cont.
Country, Setting Study period Diagnostic criteria
Mean age
(years)
Prevalence %
(all)
Prevalence %
(men)
Prevalence %
(women)
Nigeria, Rural [123] 2004–05 $140/90 mmHg 30.7 20.2 24.8 13.2
Nigeria, Semi-urban [124] 2011 JNC 7 50.5 15 18.8 12.5
Nigeria, Mixed [125] 2007–08 $140/90 mmHg 40.8 32.8 - -
Nigeria, Mixed [126] 2009–10 WHO/ISH 2003 38.02 42.2 46.3 37.7
Senegal, Urban [127] 1989–90 $140/90 mmHg 31.45 22.5 23.6 21.5
Senegal, Urban [26] 2009 $140/90 mmHg 69.5 65.4 63.9 67.1
Togo, Urban [128] 2009–10 $140/90 mmHg 39 26.6 25.7 27.6
Togo, Urban [129] 2011 $140/90 mmHg 40.8 36.7 34.6 38.4
JNC: Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, WHO/ISH: World Health Organization/International Society
of Hypertension.
doi:10.1371/journal.pone.0104300.t004
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an overall mean SBP in SSA ranging 129.2–132.7 mm Hg and
132.6–134.8 mm Hg among men and women, respectively,
between 1981 and 2008 [29]. This study further supports our
finding of a high prevalence of hypertension in Africa, with the
highest value of SBP globally estimated in SSA (along with central
and eastern Europe) [29].
Across selected studies, higher prevalence rates of hypertension
were reported with increasing age of subjects. This is underpinned
by previous research findings where increasing age is associated
with significant increase in the prevalence of hypertension,
especially in people aged $60 years [12,21]. For example, a
higher prevalence of hypertension was reported in Northern Africa
with a pooled prevalence of 33.3% compared to a prevalence of
27.8% in SSA. This could be partly explained by age difference,
with a mean age of 54.3 years in Northern Africa, compared to
46.4 years in SSA. In the 2009 hospital-based Epidemiological
Trial of Hypertension in North Africa (ETHNA), a high
prevalence (45.4%, mean age 49.2 years) was also reported for
Northern Africa [30]; this further supports findings of this study.
A higher prevalence of hypertension was noted among urban
dwellers from the pooled estimates mainly in 1990 (urban 17.2%,
rural 11.1%), while the prevalence was virtually the same in years
2000 and 2010. The narrowing of prevalence gaps between urban
and rural dwellers in years 2000 and 2010 could be due to a
possible reverse rural-urban migration, which has been reported
when urban dwellers fail to cope with the economic challenges and
vulnerabilities associated with urban life, and may prefer to return
to natural resource-rich rural settlements [31]. In addition, there
are reports that even in rural settings, the apparent remote and
traditional styles do not seem to protect them again, as more of
these rural settings are gradually becoming semi-urbanized [3].
Opie and colleagues also argued that many site-specific hyperten-
sion prevalence estimates in Africa may not truly reflect the
burden in these settings, as there are still doubts on the proportion
of Africans that truly reside in rural settings [32].
Meanwhile, an increasing, yet low, awareness rate of hyperten-
sion in Africa was reported, with pooled weighted awareness rate
of 16.9% in 1990, 29.2% in 2000 and 33.7% in 2010. This
estimate, to the best knowledge of our knowledge, remains the first
weighted continent-wide awareness rate of hypertension reported
in Africa, and thus forms an important finding of this study. The
low awareness rate reported may still reflect a poor response to
management of hypertension in the continent [33]. Kayima et al.
corroborates this, reporting a very low awareness rate of
hypertension ranging between 8% and 10% in Africa in the early
2000s [8].
In this review, the general sex distribution showed that the
prevalence and cases of hypertension were higher among men
than women. This is also in line with many reports in Africa
[3,8].This may be because the overall mean age from all selected
studies was 47.4 years, which is just about a reported mean
menopause age of 49.4 years among African women [34], and
there is established evidence of a steeper blood pressure rise in men
than women before the age of menopause [35]. We further
estimated that there was a drop in hypertension prevalence among
women between 2010 and 2030; Danaei and colleagues reported
similar findings between 1981 and 2008, where, in contrast to a
predominant rise in mean SBP among men, the mean SBP among
women increased only in two countries globally between 1981 and
2008 [29]. Our estimate may therefore just be reflective of a
continuation in this trend. Still, from the modelling, over 54.6
million cases of hypertension were estimated in 1990 (19.1%), 92.3
Figure 2. Epidemiological model showing distribution of
hypertension prevalence according to age in both sexes, with
size of bubble corresponding to respective sample size (A:
1990, B: 2000, C: 2010).
doi:10.1371/journal.pone.0104300.g002
Figure 3. Epidemiological model showing distribution of
hypertension prevalence according to age among men, with
size of bubble corresponding to respective sample size (A:
1990, B: 2000, C: 2010).
doi:10.1371/journal.pone.0104300.g003
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million cases in 2000 (24.3%), 130.2 million cases in 2010 (25.9%),
and a projected increase to 216.8 million cases of hypertension by
2030 (25.3%). These estimates are higher than the 20 million
reported by WHO African regional office (AFRO) in 2005 [36].
The WHO AFRO estimate was based on $160/95 mm Hg and
this is probably the reason for the low hypertension cases reported.
However, reports show that this figure has often been quoted in
many official documents as the number of hypertension cases in
Africa [4]. Meanwhile, Twagirumukiza et al. estimated about 75
million cases (16.2%) of hypertension among people aged $15
years in SSA in 2008, and projected to increase to 125.5 million
cases (17.4%) in 2025 (Table 10) [15]. These figures are relatively
low compared to the current estimates. It is understandable that
these estimates were for SSA and that the mean age was low (40
years), they may yet not reflect the true burden of hypertension in
the continent, as their review and analysis mainly included studies
from 11 countries in Africa. In addition, another reviewer also
noted these concerns, and agreed the estimates were very low
compared to recent prevalence rates reported in Africa, and may
be erroneously interpreted that the burden of hypertension in the
continent is low [37]. However, Kearney et al. reported higher
hypertension estimates, with about 79.8 million hypertension cases
(27.6%) estimated among people aged $20 years in 2000 and
projected to reach about 150.7 million cases (27.7%) in 2025 [6].
These prevalence rates are comparable with the current estimates,
but the difference in the number of hypertension cases may be due
to the fact that demographic changes as reported by the United
Nations population projections were considered. Kearney et al.
also reported a minimal change in hypertension prevalence rates
between 2000 and 2025 (27.6% versus 27.7%) [6], which is also
comparable with the current estimates for 2000 and 2030 (24.3%
versus 25.3%) (Table 10). This may be due to a potentially better
public health response to the overall management of hypertension
in many African countries.
Study limitations
The study aims to provide an improved continent-wide estimate
of hypertension in Africa using current definitions (cut off ‘‘$140/
90 mm Hg’’). However, the study has some important limitations.
First, the modelling was age-dependent, we understand there are
other important social and health determinants that could have
resulted in varying estimates if considered, including, but not
limited to the overall population characteristics, socio-economic
factors and general living conditions [38]. In addition, the overall
mean age was 47.4 years, which could also have resulted in a lower
prevalence estimate, as research evidences show significant
increase in hypertension prevalence in people aged $60 years
[21]. Second, all studies included in our modelling were based on
the blood pressure cut off ‘‘$140/90 mm Hg’’; notwithstanding,
some studies have varying designs and blood pressure measuring
protocols, which could have affected the quality of the current
estimates. Moreover, while we ensured all studies that were graded
as high and moderate quality were included in the quantitative
analysis, some low quality studies were also included in the
quantitative analysis on the basis of good study designs, which
could potentially affect our overall estimates (See Box S1, Table
S1 and Table S2 in File S1).
Third, not all studies reported age- and sex- specific estimates,
including urban or rural site-specific estimates, as an epidemiology
of the prevalence of hypertension in these sub-groups could have
been further helpful. Furthermore, the incompleteness of data
across many studies prevented us from providing estimates on the
control and treatment of hypertension in Africa. We still hope that
providing a continent-wide estimate of the awareness rate of
hypertension may further give a general view of the public health
response to the disease in the continent. However, we extracted
data from 92 studies conducted in 31 African countries (having
overall sample size of 197734), and with a consideration of the
United Nations population demographics in the epidemiological
Figure 4. Epidemiological model showing distribution of
hypertension prevalence according to age among women,
with size of bubble corresponding to respective sample size (A:
1990, B: 2000, C: 2010).
doi:10.1371/journal.pone.0104300.g004
Figure 5. Epidemiological model showing distribution of
hypertension prevalence according to age (projections for
2030), with size of bubble corresponding to respective sample
size (A: both sexes, B: men, C: women).
doi:10.1371/journal.pone.0104300.g005
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modelling. The current estimates may therefore provide fair
representation of the overall African population and better reflect
the prevalence and number of cases of hypertension in the
continent.
Challenges and public health response to hypertension
in Africa
Recent reports show that the World Heart Federation,
supported by the Pan African Society of Cardiology (PASCAR),
has been actively building capacities across Africa to address the
rising burden of hypertension and other cardiovascular diseases in
the continent [39]. However, collaborations and response within
Africa remains poor, as hypertension still ranks low among health
priorities, owing to competition for the limited resources from a
co-existing high burden of infectious diseases [5]. Moreover, in
countries with some levels of care for hypertension, the standards
of health service delivery is poor [3]. Many cases of hypertension
are detected late, treatments rarely follow standard guidelines, and
the costs of medications are generally high [35]. Besides, health
care seeking behaviour has also been affected, with people often
preferring low-cost substandard health facilities [40]. This is
particularly a problem in rural settings where the prevalence of
hypertension has been reported to be on a gradual increase [8].
Further reports show that even with a relatively lower prevalence
of hypertension among rural dwellers, the detection and overall
management are poor in comparison to urban dwellers [3].
Additionally, many African countries are yet to implement
population-wide control measures to address risk factors for
hypertension [41], even with confirmed reports of high salts and
fats consumption in the region and evidence showing cost-
effectiveness of interventions targeting this [42,43]. The WHO
now recommends country-specific initiatives and legislation
concerning food labelling and products formulation, including
sodium and saturated fats content in processed foods [2,39].
Conclusions
This study suggests a high prevalence of hypertension in Africa,
and the awareness of the disease, though increasing, still remains
low. Hypertension deserves to be on the health priority lists of
African nations, and problems with funding may possibly be
reduced by partnering with leading international bodies for
cardiovascular diseases. Essentially, policy makers and stakehold-
ers in the health sector need to institute nationwide population-
based strategies towards creating awareness on hypertension and
educating people on the main risk factors such as smoking,
harmful use of alcohol, sedentary lifestyles and unhealthy diets. It
is hoped that the findings of this review may prompt appropriate
policy response at country level towards improved detection,
control and overall management of hypertension in Africa.
Supporting Information
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(DOC)
File S1 Box S1, Brief details of quality criteria of retained studies
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